AAO
Session: RET22
Title: Topline 24-Month Results from the Phase 3 DRAGON Study of Tinlarebant for Adolescent Stargardt Disease
Presenter: Quan Dong Nguyen, M.D., Professor of Ophthalmology at the Byers Eye Institute and Professor of Pediatrics and Professor of Medicine (Immunology and Rheumatology), Stanford University School of Medicine
Date and Time: October 10, 2026, 4:18 – 4:23 p.m. CDT
Location: Morial Convention Center, New Orleans Theater
Session: PA043
Title: Phase 3 DRAGON Trial of Tinlarebant for Stargardt Disease (STGD1)
Presenter: Jacque L. Duncan, M.D., Department Chair and Professor of Ophthalmology, University of California, San Francisco School of Medicine
Date and Time: October 11, 2026, 11:30 – 11:37 a.m. CDT
Location: Morial Convention Center, Room 255-257